Tell your friends about this item:
The Challenge of CMC Regulatory Compliance for Biopharmaceuticals John Geigert Fourth Edition 2023 edition
Price
NZ$ 277
excl. VAT
Ordered from remote warehouse
Expected delivery Sep 17 - 29
Get notified about new John Geigert releases
Add to your iMusic wish list
Also available as:
-
Hardcover BookThird Edition 2019 edition(2019) NZ$ 277
-
Hardcover BookFifth Edition 2026 edition(2026) NZ$ 310.50
-
Paperback BookSecond Edition 2013 edition(2016) NZ$ 310.50
-
Hardcover Book2004 edition(2003) NZ$ 353.50
-
Paperback BookSoftcover reprint of the original 1st ed. 2004 edition(2012) NZ$ 353.50
-
Hardcover BookSecond Edition 2013 edition(2013) NZ$ 428.50
The Challenge of CMC Regulatory Compliance for Biopharmaceuticals
John Geigert
In summary, this book:Updates real-world CMC deficiency examples with current examples;Addresses current FDA and EMA requirements and expectations for CMC regulatory compliance;Now includes CMC regulatory compliance for the new gene-based biopharmaceuticals.
573 pages, 1 Illustrations, black and white; XXXV, 573 p. 1 illus.
| Media | Books Paperback Book (Book with soft cover and glued back) |
| Released | June 16, 2024 |
| ISBN13 | 9783031319112 |
| Publishers | Springer International Publishing AG |
| Pages | 573 |
| Dimensions | 150 × 220 × 10 mm · 914 g |
| Language | German |